This is a Epoch news story, published by TechCrunch, that relates primarily to Epoch Biodesign news.
For more Epoch news, you can click here:
more Epoch newsFor more Epoch Biodesign news, you can click here:
more Epoch Biodesign newsFor more emerging technologies news, you can click here:
more emerging technologies newsFor more news from TechCrunch, you can click here:
more news from TechCrunchOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best tech news, business news, entertainment news, and much more. If you like emerging technologies news, you might also like this article about
plastic waste problem. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest plastic waste news, plastic pollution cycle news, emerging technologies news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
global plastic crisisTechCrunch
•Technology
Technology
75% Informative
Epoch Biodesign has secured an oversubscribed $18.3 million in Series A funding.
Founded in 2019 in London , the startup is developing a library of plastic-eating enzymes with the goal of disrupting the plastic pollution cycle by powering up biorecycling-based circularity.
The first materials they’ve developed enzymes to tackle are polyester and two types of nylon (nylon 6 and nylon 66 ).
Epoch ’s AI-driven enzyme design search has enabled it to “pretty regularly” get speed improvements on enzymes in the region of 25x .
The startup has built three “best-in-class processes to recycle three very chemically distinct types of plastics” and scaling those to commercially useful volumes is next.
Epoch Biodesign’s Series A includes a strategic investment by Spanish fast fashion giant Inditex .
The company has inked a multi-year “joint development agreement” with Epoch .
The Series A round is led by Extantia Capital , with Day One Ventures, Happiness Capital , Kibo Invest , Lowercarbon Capital and others also participating.
VR Score
68
Informative language
61
Neutral language
53
Article tone
informal
Language
English
Language complexity
59
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
4
Source diversity
4
Affiliate links
no affiliate links
